Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease

Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease

Huntington’s disease (HD) is a rare neurodegenerative disease that is accompanied by skeletal muscle atrophy and cardiomyopathy. Tissues affected by HD (central nervous system [CNS], skeletal muscle, and heart) are known to suffer from deteriorated cellular energy metabolism that manifests already a...

Full description

Bibliographic Details
Main Authors: Marta Tomczyk, Alicja Braczko, Paulina Mierzejewska, Magdalena Podlacha, Oliwia Krol, Patrycja Jablonska, Agata Jedrzejewska, Karolina Pierzynowska, Grzegorz Wegrzyn, Ewa M. Slominska, Ryszard T. Smolenski
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cells
Subjects:
Huntington’s disease
myopathy
cardiomyopathy
rosiglitazone
molecular mechanisms
therapy
Online Access:https://www.mdpi.com/2073-4409/11/17/2662

Internet

https://www.mdpi.com/2073-4409/11/17/2662

Similar Items